Sadick NS - Search Results

1

Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.

Sadick NS, Faacs. Sadick NS, et al. Dermatol Surg. 2002 Sep;28(9):817-21. doi: 10.1046/j.1524-4725.2002.02037.x. Dermatol Surg. 2002. PMID: 12269875 Clinical Trial.

2

Botulinum toxin type B.

Sadick NS. Sadick NS. Dermatol Surg. 2003 Apr;29(4):348-50; discussion 350-1. doi: 10.1046/j.1524-4725.2002.29083.x. Dermatol Surg. 2003. PMID: 12656811 Review.

3

Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.

Sadick NS. Sadick NS. Dermatol Surg. 2003 May;29(5):501-7; discussion 507. doi: 10.1046/j.1524-4725.2003.29122.x. Dermatol Surg. 2003. PMID: 12752518 Clinical Trial.

4

Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides.

Sadick NS, Herman AR. Sadick NS, et al. Dermatol Surg. 2003 Apr;29(4):340-7. doi: 10.1046/j.1524-4725.2003.29082.x. Dermatol Surg. 2003. PMID: 12656810 Review.

5

Comparison of botulinum toxins A and B in the treatment of facial rhytides.

Sadick NS, Matarasso SL. Sadick NS, et al. Dermatol Clin. 2004 Apr;22(2):221-6. doi: 10.1016/s0733-8635(03)00040-8. Dermatol Clin. 2004. PMID: 15222583

6

Nonablative wrinkle treatment of the face and neck using a combined diode laser and radiofrequency technology.

Sadick NS, Trelles MA. Sadick NS, et al. Dermatol Surg. 2005 Dec;31(12):1695-9. doi: 10.2310/6350.2005.31310. Dermatol Surg. 2005. PMID: 16336889 Clinical Trial.

7

Aesthetic uses of the botulinum toxin.

Dorizas A, Krueger N, Sadick NS. Dorizas A, et al. Among authors: sadick ns. Dermatol Clin. 2014 Jan;32(1):23-36. doi: 10.1016/j.det.2013.09.009. Dermatol Clin. 2014. PMID: 24267419 Review.

8

Utilization of the 1320-nm Nd:YAG laser for the reduction of photoaging of the hands.

Sadick N, Schecter AK. Sadick N, et al. Dermatol Surg. 2004 Aug;30(8):1140-4. doi: 10.1111/j.1524-4725.2004.30341.x. Dermatol Surg. 2004. PMID: 15274706 Clinical Trial.

9

The cosmetic use of botulinum toxin type B in the upper face.

Sadick NS. Sadick NS. Clin Dermatol. 2004 Jan-Feb;22(1):29-33. doi: 10.1016/j.clindermatol.2003.12.033. Clin Dermatol. 2004. PMID: 15158542 Review.

10

A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.

Sadick NS, Katz BE, Roy D. Sadick NS, et al. Dermatol Surg. 2007 Dec;33 Suppl 2:S122-6; discussion S126-7. doi: 10.1111/j.1524-4725.2007.33351.x. Dermatol Surg. 2007. PMID: 18086049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page